Literature DB >> 16949282

Synthesis of 3,6-bis[H-Tyr/H-Dmt-NH(CH2)m,n]-2(1H)pyrazinone derivatives: function of alkyl chain length on opioid activity.

Kimitaka Shiotani1, Tingyou Li, Anna Miyazaki, Yuko Tsuda, Sharon D Bryant, Akihiro Ambo, Yusuke Sasaki, Lawrence H Lazarus, Yoshio Okada.   

Abstract

Dimeric opioid analogues linked to a pyrazinone platform, 3-[Tyr/Dmt-NH(CH2)m]-6-[Tyr/Dmt-NH(CH2)n]-2(1H)-pyrazinone (m, n=3 or 4), were synthesized. The Tyr-containing compound (m=4, n=3) exhibited mu-receptor affinity (K(i)mu; 7.58 nM) comparable to that of morphine, while the Dmt derivatives exhibited considerably higher affinity (K(i)mu; 0.021-0.051 nM) with corresponding agonism (IC50=1.79-4.93 nM). Interestingly one compound (m=4, n=3) revealed modest delta-opioid agonism; the converse analogue (m=3, n=4), however, was inactive in MVD assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949282      PMCID: PMC2636969          DOI: 10.1016/j.bmcl.2006.08.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin.

Authors:  B M Cox; A Goldstein; C H Hi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond.

Authors:  Yoshio Okada; Yoshio Fujita; Takashi Motoyama; Yuko Tsuda; Toshio Yokoi; Tingyou Li; Yusuke Sasaki; Akihiro Ambo; Yunden Jinsmaa; Sharon D Bryant; Lawrence H Lazarus
Journal:  Bioorg Med Chem       Date:  2003-05-01       Impact factor: 3.641

4.  Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists.

Authors:  Tingyou Li; Yunden Jinsmaa; Masahiro Nedachi; Anna Miyazaki; Yuko Tsuda; Akihiro Ambo; Yusuke Sasaki; Sharon D Bryant; Ewa Marczak; Qiang Li; H Scott Swartzwelder; Lawrence H Lazarus; Yoshio Okada
Journal:  Bioorg Med Chem       Date:  2006-11-14       Impact factor: 3.641

5.  Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei.

Authors:  P C Montecucchi; R de Castiglione; S Piani; L Gozzini; V Erspamer
Journal:  Int J Pept Protein Res       Date:  1981-03

6.  Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr.

Authors:  Y Sasaki; T Suto; A Ambo; H Ouchi; Y Yamamoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-10       Impact factor: 1.645

7.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

8.  Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.

Authors:  M Broccardo; V Erspamer; G Falconieri Erspamer; G Improta; G Linari; P Melchiorri; P C Montecucchi
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

9.  Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.

Authors:  Yoshio Okada; Yuko Tsuda; Yoshio Fujita; Toshio Yokoi; Yusuke Sasaki; Akihiro Ambo; Ryoji Konishi; Mitsuhiro Nagata; Severo Salvadori; Yunden Jinsmaa; Sharon D Bryant; Lawrence H Lazarus
Journal:  J Med Chem       Date:  2003-07-17       Impact factor: 7.446

10.  Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia.

Authors:  Yunden Jinsmaa; Anna Miyazaki; Yoshio Fujita; Tingyou Li; Yutaka Fujisawa; Kimitaka Shiotani; Yuko Tsuda; Toshio Yokoi; Akihiro Ambo; Yusuke Sasaki; Sharon D Bryant; Lawrence H Lazarus; Yoshio Okada
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

View more
  2 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability.

Authors:  Sean P Henry; Thomas J Fernandez; Jessica P Anand; Nicholas W Griggs; John R Traynor; Henry I Mosberg
Journal:  J Med Chem       Date:  2019-04-12       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.